UNSPSC 51171985: Vestronidase alfa

Vestronidase alfa is a therapy intended to replace the deficient lysosomal enzyme beta-glucuronidase to help break down the glycosaminoglycans that accumulate in the tissues of patients with MPS 7.

UNSPSC 51171985 Vestronidase alfa is a Commodity code that nominally identifies a single therapeutic enzyme product, yet the recent state and local opportunities posted under this code show no procurement activity for vestronidase alfa itself. Instead, the opportunities span a broad range of pharmaceutical supply, services, and equipment procurement—from emergency medical services (EMS) drug-dispensing software and basic and advanced life support (BLS/ALS) pharmaceuticals to naloxone nasal spray, parenteral nutrition solutions, pharmacy benefits management, and medication dispensing services. The mismatch between the code's narrow product scope and the actual work being solicited suggests this code either functions as a catch-all pharmaceutical commodity marker in certain state procurement systems or has been applied inconsistently across jurisdictions. Issuing bodies include state departments (Washington Department of Corrections, New Jersey Department of the Treasury, Illinois Chief Procurement Office), county health departments and boards (Collier County Florida, Forsyth County Georgia, DeKalb County Georgia, Seminole County Florida), municipal fire and police departments (City of Tucson), and specialized public health agencies (DeKalb Public Health). No single buyer appears repeatedly; the activity reflects fragmented, decentralized procurement across multiple government types and service missions.

Recent opportunities span the Southeast (Florida, Georgia), Mid-Atlantic (New Jersey), Northwest (Washington), Southwest (Arizona), and Midwest (Illinois). Representative solicitations include Collier County's notice of intent to single-source Handtevy, a mobile drug-dosage calculation application with EMS protocol integration (protest deadline September 24, 2026), Washington Department of Corrections' RFQ for parenteral nutrition and intravenous solutions across eight correctional facilities with awards to up to three vendors per region (due October 7, 2026), New Jersey Department of Human Services' IFB for FDA-approved naloxone 4mg nasal spray with delivery to 1,500 eligible entities statewide at historical volumes of 223,000 to 265,500 cartons annually (due October 27, 2026), City of Tucson Fire Department's RFP for BLS/ALS pharmaceuticals, supplies, and VendNovation vending machines with 251 line items (deadline passed June 24, 2026), and DeKalb Public Health's RFQ for primary care medication dispensing services for Ryan White patients (due July 27, 2026). The code shows active but scattered activity with no concentration in a single state or jurisdiction type, and procurement drivers range from community opioid response initiatives to correctional healthcare to municipal emergency services to employee benefits administration.